Speakers from Pulsar Helium and Eurasia Mining are presenting and taking Q&A at focusIR's Investor Webinar next week. Register here.

Less Ads, More Data, More Tools Register for FREE
Sponsored Content
Don't want ads? Click here
Sponsored Content
Don't want ads? Click here

Pin to quick picksIQ-AI Share News (IQAI)

Share Price Information for IQ-AI (IQAI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.825
Bid: 0.80
Ask: 0.85
Change: 0.00 (0.00%)
Spread: 0.05 (6.25%)
Open: 0.825
High: 0.825
Low: 0.825
Prev. Close: 0.825
IQAI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Timelines are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Ingenta trades in line; Triple Point Social NAV up

Fri, 17th May 2024 17:39

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Friday and not separately reported by Alliance News:

----------

Condor Gold PLC - Gold exploration company with operations focused on Nicaragua - Pretax loss narrows 33% to GBP1.7 million in 2023 from GBP2.5 million in 2022. The firm says: "The company remains convinced that the 587 square kilometres La India project is a major gold district with the potential for significant future discoveries. Condor's geologists have identified two major north-northwest-striking mineralised basement feeder zones traversing the project, the 'La India Corridor', which hosts 90% of Condor's gold mineral resource and the 'Andrea Los Limones Corridor'. Numerous geophysics, soil geochemistry and surface rock chips indicate the possibility for further mineralisation along strike."

----------

Ethernity Networks Ltd - Lod, Israel-based supplier of data processing semiconductor technology for networking appliances - Enters into structured investment deed with New Technology Capital Group LLC. New Tech will invest GBP800,000 into Ethernity, expected next week. Relating to this, Ethernity will issue 40.0 million new shares to New Tech. Ethernity Chief Executive Officer David Levi says: "We have strong confidence in the company's future prospects, anticipating a rise in the company's value as we embark on strategic initiatives."

----------

Fulcrum Metals PLC - mineral explorer in Canada - Says it has been fully engaged in working towards the completion of the sale of its uranium portfolio in Saskatchewan to Terra Balcanica Resources Corp. CEO Ryan Mee says: "Certain steps under that process have, unfortunately, taken longer than anticipated, but we are confident that the acquisition will be completed by the extended back stop date of 15 June 2024."

----------

Ingenta PLC - Oxford, England-based provider of software and services to the publishing industry - Says it intends to release its 2023 results this month, noting that underlying trading performance is expected to be as it announced in January. "Current trading continues to be in line with management expectations, with cash flow ahead of budget and the company on track to deliver a further year of solid progress," Ingenta says.

----------

IQ-AI Ltd - medical services firm - Notes that its subsidiary Imaging Biometrics announces the successful deployment of its software at Insel Gruppe AG in Bern, Switzerland. Imaging Biometrics CEO Michael Schmainda says: "The installation at Insel Gruppe AG allows them full access to our comprehensive suite of applications. We are excited about this collaboration and are committed to supporting Insel Gruppe AG as they set new standards in patient care."

----------

Oracle Power PLC - energy projects developer - Says two drill rigs are contracted to start drilling at the Northern Zone gold project in Western Australia next week. CEO Naheed Memon says: "We have a very large gold exploration target here, which is centred around a large porphyry gold system that has been proven to be over 100 metres in true width."

----------

Pathfinder Minerals PLC - AIM-listed cash shell seeking reverse takeover - Says on Thursday received outstanding balance of GBP30,000 from the subscriber regarding a subscription of around GBP1.3 million. It adds that there is no outstanding balance due from the subscriber.

----------

Sivota PLC - investor in later-stage Israeli technology firms - Says that negotiations with an online technology platform have terminated after the signing of a non-binding term sheet back in January. Back then, Sivota said it intended to raise about GBP250,000 via share placing. With the termination, the signing of a definitive agreement will not proceed. "The company remains committed to exploring further merger & acquisition activity and is evaluating its pipeline opportunities," Sivota says.

----------

Technology Minerals PLC - London-based battery metals and recycling firm - Gives notice to Atlas Capital Market LLC of a draw down of GBP600,000 to be issued on May 30. "Use of the new funds rawn will include continued support of the scale up in operations at Recyclus' lithium-ion plant in Wolverhampton, ahead of the proposed acquisition of the shares not held by the company, as previously announced," the company explains. Technology holds a stake of around 48.35% in Recyclus Group Ltd.

----------

Triple Point Social Housing REIT PLC - London-base property investor - Appoints Akur Ltd to conduct independent review of investment management arrangements. Separately, reports net asset value per share of 114.15 pence as at March 31, up 0.3% from 113.76p at December 31.

----------

UK Oil & Gas PLC - oil and gas with assets in UK and Turkey - Says regarding a funding facility announced in June 2023, principal balance stands at about GBP370,000 of GBP2 million gross first cash sum received.

----------

By Tom Budszus, Alliance News slot editor

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
10 Jan 2024 11:48

IQ-AI falls after subsidiary notes launch of treatment access scheme

(Alliance News) - IQ-AI Ltd shares fell on Wednesday, after it said its subsidiary Imaging Biometrics LLC is launching an intermediate population cohort expanded access programme for oral gallium maltolate.

Read more
19 Dec 2023 17:00

IQ-AI firm gets US FDA fast-track status for oral gallium maltolate

(Alliance News) - IQ-AI Ltd on Tuesday said the US Food & Drug Administration has granted 'fast-track" designation for oral gallium maltolate, which is its subsidiary Imaging Biometrics LLC's therapeutic for the treatment of adult patients with relapsed or refractory glioblastoma.

Read more
5 Dec 2023 11:49

IQ-AI stock rises on positive interim results from glioblastoma trial

(Alliance News) - IQ-AI Ltd on Tuesday reported positive results from Phase 1 of an on-going study for its investigational monotherapy oral gallium maltolate.

Read more
8 Nov 2023 12:04

IQ-AI says Imaging Biometrics submits paediatric rare disease request

(Alliance News) - IQ-AI Ltd on Wednesday said its wholly-owned subsidiary Imaging Biometrics LLC has submitted a paediatric rare disease request to the US Food & Drug Administration for its gallium maltolate therapy.

Read more
18 Oct 2023 17:11

IN BRIEF: IQ-AI subsidiary "central" to "landmark" brain cancer study

IQ-AI Ltd - St Helier, Jersey-based medical services firm focused on cancer treatment - Notes its wholly-owned subsidiary, Imaging Biometrics LLC (IB), has announced the results of a "landmark" study. Says the study represents the first large-scale characterization of the invasive tumour margins of high-grade glioma using multi-regional genomic/transcriptomic sequencing with spatially matched MRI measurements in glioma. High-grade glioma is a deadly brain cancer. Explains that Imaging Biometrics' IB Neuro's dynamic susceptibility contrast magnetic resonance imaging software was central to the study.

Read more
9 Oct 2023 12:09

IN BRIEF: IQ-AI subsidiary wins orphan drug designation from US FDA

IQ-AI Ltd - St Helier, Jersey-based medical services firm focused on cancer treatment - Wholly-owned subsidiary Imaging Biometrics LLC is granted an orphan drug designation from the US Food & Drug Administration for gallium maltolate for the treatment of atypical teratoid rhabdoid tumour. Notes this is the second orphan designation granted to gallium maltolate this year.

Read more
8 Sep 2023 10:25

IQ-AI notes vindication of subsidiary's reduced gadolinium approach

(Alliance News) - IQ-AI Ltd on Friday noted that studies by its subsidiary Imaging Biometrics LLC validated the dosing approach of Imaging's MRI-focused IB Neuro.

Read more
18 Aug 2023 12:17

IQ-AI shares jump on subsidiary's GE Healthcare deal

(Alliance News) - IQ-AI Ltd on Friday said its wholly-owned subsidiary Imaging Biometrics LLC has signed a deal with GE HealthCare Technologies Inc.

Read more
17 Aug 2023 11:21

IQ-AI interim loss narrows amid higher revenue, lower expenses

(Alliance News) - IQ-AI Ltd on Thursday announced a slightly lower loss for the six months to June 30, as revenue was up and administrative expenses were lower.

Read more
19 Jul 2023 10:45

IN BRIEF: IQ-AI subsidiary's app adopted by US medical college

IQ-AI Ltd - Jersey-based medical services firm focused on cancer treatment - Says subsidiary Imaging Biometrics LLC's handheld application IB Nimble has been adopted by the Medical College of Wisconsin's Orthopedic Department for use in bone metastases treatment. IB Nimble's designer, Joseph Bovi, is professor of radiation oncology & neurosurgery at MCW. The application was originally designed to help treat brain metastases. IQ-AI says it "provides real-time collaboration amongst multi-disciplinary teams" to "provide optimised treatments faster". Josh McComack, Imaging Biometrics' director of software engineering, says the new installation "demonstrates that IB Nimble is ready for widespread deployment."

Read more
13 Jul 2023 11:36

IN BRIEF: IQ-AI granted orphan drug designation for Gallium Galtolate

IQ-AI Ltd on Thursday - Jersey-based incubator of software and other tools for the treatment of cancer - IQ-AI subsidiary Imaging Biometrics LLC has been granted an orphan drug designation for Gallium Galtolate for the treatment of paediatric glioblastoma multiforme, or GBM, by the US Food & Drug Administration. Says GBM is the most common and aggressive primary brain tumour in adults and children. Imaging Biometrics' application to the FDA was first submitted in April. In June, two pre-clinical studies showed oral GaM inhibits brain tumour growth in children, and the results were consistent with previous work conducted in the Schmainda Lab at the Medical College of Wisconsin.

Read more
27 Jun 2023 11:47

IN BRIEF: IQ-AI notes Gallium Moltate studies on tumour growth

IQ-AI Ltd - Jersey-based medical services firm - Says subsidiary Imaging Biometrics LLC's two new pre-clinical studies show oral Gallium Maltolate inhibits brain tumour growth in children. Says the results are consistent with previous work conducted in the Schmainda Lab at the Medical College of Wisconsin. This follows IB's application for Orphan Drug Designation to the US Food & Drug Administration back in April for the use of GaM in pediatric brain tumours. Notes application is currently under review.

Read more
23 May 2023 16:12

TRADING UPDATES: Harworth optimistic on 2027; Plexus extends agreement

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
16 May 2023 15:53

UK shareholder meetings calendar - next 7 days

Read more
26 Apr 2023 14:43

EARNINGS SUMMARY: Third Point Investors NAV per share drops by quarter

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.